Magnetic resonance imaging of breast cancer: does the time interval between biopsy and MRI influence MRI-pathology discordance in lesion sizing?

Simone Mennella, Francesco Paparo, Matteo Revelli, Paola Baccini, Lucia Secondini, Stella Barbagallo, Daniele Friedman, Alessandro Garlaschi

Research output: Contribution to journalArticle

Abstract

Background Breast magnetic resonance imaging (MRI) is more accurate than ultrasound and mammography in estimating local extension of both invasive breast cancer and ductal carcinoma in situ (DCIS) and it is part of a breast cancer patient's preoperative management. Purpose To verify if time interval between breast biopsy and preoperative MRI, lesion margins, and biopsy technique can influence tumor sizing on MRI. Material and Methods By a database search, we retrospectively identified all women with a newly diagnosed, biopsy-proven, primary breast cancer who underwent MRI before surgery. The time interval between biopsy and MRI, the type of biopsy procedure, and various pathological features of tumors were collected. We defined the concordance between MRI and pathology measurements as a difference of <5 mm in lesion sizing. Results One hundred and sixty-six women (mean age, 51.4 ± 10.4 years) were included. The time interval between biopsy and MRI showed only a weak correlation with the absolute MRI-pathology difference (r = 0.236). Stratifying the whole cohort of patients using a cutoff value of 30 days, we found that the MRI-pathology discordance was significantly higher in patients with a biopsy-MRI time interval >30 days ( P < 0.05). By means of multivariate analysis, we found that DCIS subtype and the presence of poorly defined margins on MRI are the only two factors independently and strongly associated with MRI-pathology discordance in lesion sizing. Conclusion Size, histology, and margins of tumors may affect the accuracy of MRI measurements. The type of biopsy procedure and the time interval between biopsy and preoperative MRI are not independently associated to MRI-pathology discordance.

Original languageEnglish
Pages (from-to)284185116674498
JournalActa Radiologica
DOIs
Publication statusE-pub ahead of print - Jan 1 2016

Fingerprint

Magnetic Resonance Imaging
Pathology
Breast Neoplasms
Biopsy
Carcinoma, Intraductal, Noninfiltrating
Breast
Mammary Ultrasonography
Neoplasms
Histology
Multivariate Analysis
Databases

Keywords

  • Journal Article

Cite this

Magnetic resonance imaging of breast cancer : does the time interval between biopsy and MRI influence MRI-pathology discordance in lesion sizing? / Mennella, Simone; Paparo, Francesco; Revelli, Matteo; Baccini, Paola; Secondini, Lucia; Barbagallo, Stella; Friedman, Daniele; Garlaschi, Alessandro.

In: Acta Radiologica, 01.01.2016, p. 284185116674498.

Research output: Contribution to journalArticle

Mennella, Simone ; Paparo, Francesco ; Revelli, Matteo ; Baccini, Paola ; Secondini, Lucia ; Barbagallo, Stella ; Friedman, Daniele ; Garlaschi, Alessandro. / Magnetic resonance imaging of breast cancer : does the time interval between biopsy and MRI influence MRI-pathology discordance in lesion sizing?. In: Acta Radiologica. 2016 ; pp. 284185116674498.
@article{768004555b674fff8ed168ffaee99b9f,
title = "Magnetic resonance imaging of breast cancer: does the time interval between biopsy and MRI influence MRI-pathology discordance in lesion sizing?",
abstract = "Background Breast magnetic resonance imaging (MRI) is more accurate than ultrasound and mammography in estimating local extension of both invasive breast cancer and ductal carcinoma in situ (DCIS) and it is part of a breast cancer patient's preoperative management. Purpose To verify if time interval between breast biopsy and preoperative MRI, lesion margins, and biopsy technique can influence tumor sizing on MRI. Material and Methods By a database search, we retrospectively identified all women with a newly diagnosed, biopsy-proven, primary breast cancer who underwent MRI before surgery. The time interval between biopsy and MRI, the type of biopsy procedure, and various pathological features of tumors were collected. We defined the concordance between MRI and pathology measurements as a difference of <5 mm in lesion sizing. Results One hundred and sixty-six women (mean age, 51.4 ± 10.4 years) were included. The time interval between biopsy and MRI showed only a weak correlation with the absolute MRI-pathology difference (r = 0.236). Stratifying the whole cohort of patients using a cutoff value of 30 days, we found that the MRI-pathology discordance was significantly higher in patients with a biopsy-MRI time interval >30 days ( P < 0.05). By means of multivariate analysis, we found that DCIS subtype and the presence of poorly defined margins on MRI are the only two factors independently and strongly associated with MRI-pathology discordance in lesion sizing. Conclusion Size, histology, and margins of tumors may affect the accuracy of MRI measurements. The type of biopsy procedure and the time interval between biopsy and preoperative MRI are not independently associated to MRI-pathology discordance.",
keywords = "Journal Article",
author = "Simone Mennella and Francesco Paparo and Matteo Revelli and Paola Baccini and Lucia Secondini and Stella Barbagallo and Daniele Friedman and Alessandro Garlaschi",
year = "2016",
month = "1",
day = "1",
doi = "10.1177/0284185116674498",
language = "English",
pages = "284185116674498",
journal = "Acta Radiologica",
issn = "0284-1851",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Magnetic resonance imaging of breast cancer

T2 - does the time interval between biopsy and MRI influence MRI-pathology discordance in lesion sizing?

AU - Mennella, Simone

AU - Paparo, Francesco

AU - Revelli, Matteo

AU - Baccini, Paola

AU - Secondini, Lucia

AU - Barbagallo, Stella

AU - Friedman, Daniele

AU - Garlaschi, Alessandro

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background Breast magnetic resonance imaging (MRI) is more accurate than ultrasound and mammography in estimating local extension of both invasive breast cancer and ductal carcinoma in situ (DCIS) and it is part of a breast cancer patient's preoperative management. Purpose To verify if time interval between breast biopsy and preoperative MRI, lesion margins, and biopsy technique can influence tumor sizing on MRI. Material and Methods By a database search, we retrospectively identified all women with a newly diagnosed, biopsy-proven, primary breast cancer who underwent MRI before surgery. The time interval between biopsy and MRI, the type of biopsy procedure, and various pathological features of tumors were collected. We defined the concordance between MRI and pathology measurements as a difference of <5 mm in lesion sizing. Results One hundred and sixty-six women (mean age, 51.4 ± 10.4 years) were included. The time interval between biopsy and MRI showed only a weak correlation with the absolute MRI-pathology difference (r = 0.236). Stratifying the whole cohort of patients using a cutoff value of 30 days, we found that the MRI-pathology discordance was significantly higher in patients with a biopsy-MRI time interval >30 days ( P < 0.05). By means of multivariate analysis, we found that DCIS subtype and the presence of poorly defined margins on MRI are the only two factors independently and strongly associated with MRI-pathology discordance in lesion sizing. Conclusion Size, histology, and margins of tumors may affect the accuracy of MRI measurements. The type of biopsy procedure and the time interval between biopsy and preoperative MRI are not independently associated to MRI-pathology discordance.

AB - Background Breast magnetic resonance imaging (MRI) is more accurate than ultrasound and mammography in estimating local extension of both invasive breast cancer and ductal carcinoma in situ (DCIS) and it is part of a breast cancer patient's preoperative management. Purpose To verify if time interval between breast biopsy and preoperative MRI, lesion margins, and biopsy technique can influence tumor sizing on MRI. Material and Methods By a database search, we retrospectively identified all women with a newly diagnosed, biopsy-proven, primary breast cancer who underwent MRI before surgery. The time interval between biopsy and MRI, the type of biopsy procedure, and various pathological features of tumors were collected. We defined the concordance between MRI and pathology measurements as a difference of <5 mm in lesion sizing. Results One hundred and sixty-six women (mean age, 51.4 ± 10.4 years) were included. The time interval between biopsy and MRI showed only a weak correlation with the absolute MRI-pathology difference (r = 0.236). Stratifying the whole cohort of patients using a cutoff value of 30 days, we found that the MRI-pathology discordance was significantly higher in patients with a biopsy-MRI time interval >30 days ( P < 0.05). By means of multivariate analysis, we found that DCIS subtype and the presence of poorly defined margins on MRI are the only two factors independently and strongly associated with MRI-pathology discordance in lesion sizing. Conclusion Size, histology, and margins of tumors may affect the accuracy of MRI measurements. The type of biopsy procedure and the time interval between biopsy and preoperative MRI are not independently associated to MRI-pathology discordance.

KW - Journal Article

U2 - 10.1177/0284185116674498

DO - 10.1177/0284185116674498

M3 - Article

C2 - 27784760

SP - 284185116674498

JO - Acta Radiologica

JF - Acta Radiologica

SN - 0284-1851

ER -